Effect of Deletion of Genes Involved in Lipopolysaccharide Core and O-Antigen Synthesis on Virulence and Immunogenicity of Salmonella enterica Serovar Typhimurium

被引:150
作者
Kong, Qingke [1 ]
Yang, Jiseon [1 ]
Liu, Qing [1 ]
Alamuri, Praveen [1 ]
Roland, Kenneth L. [1 ]
Curtiss, Roy, III [1 ,2 ]
机构
[1] Arizona State Univ, Biodesign Inst, Ctr Infect Dis & Vaccinol, Tempe, AZ 85287 USA
[2] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA
关键词
LIVE ATTENUATED SALMONELLA; RECOMBINANT PNEUMOCOCCAL PSPA; ESCHERICHIA-COLI; YERSINIA-PESTIS; PROTECTIVE EFFICACY; ORAL IMMUNIZATION; IMMUNE-RESPONSES; VACCINE VECTORS; MUTANT; EXPRESSION;
D O I
10.1128/IAI.05398-11
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Lipopolysaccharide (LPS) is a major virulence factor of Salmonella enterica serovar Typhimurium and is composed of lipid A, core oligosaccharide (C-OS), and O-antigen polysaccharide (O-PS). While the functions of the gene products involved in synthesis of core and O-antigen have been elucidated, the effect of removing O-antigen and core sugars on the virulence and immunogenicity of Salmonella enterica serovar Typhimurium has not been systematically studied. We introduced nonpolar, defined deletion mutations in waaG (rfaG), waaI (rfaI), rfaH, waaJ (rfaJ), wbaP (rfbP), waaL (rfaL), or wzy (rfc) into wild-type S. Typhimurium. The LPS structure was confirmed, and a number of in vitro and in vivo properties of each mutant were analyzed. All mutants were significantly attenuated compared to the wild-type parent when administered orally to BALB/c mice and were less invasive in host tissues. Strains with Delta waaG and Delta waaI mutations, in particular, were deficient in colonization of Peyer's patches and liver. This deficiency could be partially overcome in the Delta waaI mutant when it was administered intranasally. In the context of an attenuated vaccine strain delivering the pneumococcal antigen PspA, all of the mutations tested resulted in reduced immune responses against PspA and Salmonella antigens. Our results indicate that nonreversible truncation of the outer core is not a viable option for developing a live oral Salmonella vaccine, while a wzy mutant that retains one O-antigen unit is adequate for stimulating the optimal protective immunity to homologous or heterologous antigens by oral, intranasal, or intraperitoneal routes of administration.
引用
收藏
页码:4227 / 4239
页数:13
相关论文
共 66 条
  • [1] [Anonymous], 1989, Molecular Cloning: A Laboratory
  • [2] The transcriptional regulator RfaH stimulates RNA chain synthesis after recruitment to elongation complexes by the exposed nontemplate DNA strand
    Artsimovitch, I
    Landick, R
    [J]. CELL, 2002, 109 (02) : 193 - 203
  • [3] RfaH and the ops element, components of a novel system controlling bacterial transcription elongation
    Bailey, MJA
    Hughes, C
    Koronakis, V
    [J]. MOLECULAR MICROBIOLOGY, 1997, 26 (05) : 845 - 851
  • [4] Involvement of surface polysaccharides in the organic acid resistance of Shiga Toxin-producing Escherichia coli O157:H7
    Barua, S
    Yamashino, T
    Hasegawa, T
    Yokoyama, K
    Torii, K
    Ohta, M
    [J]. MOLECULAR MICROBIOLOGY, 2002, 43 (03) : 629 - 640
  • [6] A Live-Attenuated Vaccine for the Treatment of Urinary Tract Infection by Uropathogenic Escherichia coli
    Billips, Benjamin K.
    Yaggie, Ryan E.
    Cashy, John P.
    Schaeffer, Anthony J.
    Klumpp, David J.
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2009, 200 (02) : 263 - 272
  • [7] Different sugar residues of the lipopolysaccharide outer core are required for early interactions of Salmonella enterica serovars Typhi and Typhimurium with epithelial cells
    Bravo, Denisse
    Hoare, Anilei
    Silipo, Alba
    Valenzuela, Camila
    Salinas, Catalina
    Alvarez, Sergio A.
    Molinaro, Antonio
    Valvano, Miguel A.
    Contreras, Ines
    [J]. MICROBIAL PATHOGENESIS, 2011, 50 (02) : 70 - 80
  • [8] PspA, a protection-eliciting pneumococcal protein: Immunogenicity of isolated native PspA in mice
    Briles, DE
    King, JD
    Gray, MA
    McDaniel, LS
    Swiatlo, E
    Benton, KA
    [J]. VACCINE, 1996, 14 (09) : 858 - 867
  • [9] Use of Genetically Modified Bacteria to Modulate Adaptive Immunity
    Bueno, Susan M.
    Gonzalez, Pablo A.
    Kalergis, Alexis M.
    [J]. CURRENT GENE THERAPY, 2009, 9 (03) : 171 - 184
  • [10] CARDENAS L, 1992, CLIN MICROBIOL REV, V5, P328